Product news from the 09/26/06 News Brief

Share this article:
Allergan, maker of Botox cosmetic (Botulinum Toxin Type A), today announced it is launching its “next-generation” hyaluronic acid dermal filler products, Juvederm Ultra and Juvederm Ultra Plus. The launch will take place through an experience trial involving a group of physicians with expertise in facial aesthetics, in advance of nationwide product availability in January 2007. Allergan will begin accepting physician pre-orders for the products on Nov.1 via its nationwide sales force. The FDA approved Connetics’ Verdeso (desonide) foam for the treatment of mild-to-moderate atopic dermatitis. Verdeso, previously referred to as Desilux, is a low-potency topical steroid. Connetics expects to begin marketing Verdeso to physicians in the fourth quarter of 2006 in 50g and 100g trade unit sizes. The FDA has approved new formulation of Alcon’s Travatan Z opthalmic solution for the expanded indication of reduction of elevated intraocular pressure. The drug is recommended for patients with open-angle glaucoma or ocular hypertension, who are intolerant of or not responsive enough to other medications.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

Email Newsletters

MM&M Future Leaders


Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Business Briefs

Novartis said to be stepping out of HCV

Novartis is said to have relinquished rights to an investigational hep. C treatment, signaling its exit from the therapeutic space, according to a former partner's announcement.

Monday Moves: September 15

Hires and promotions for manufacturers, regulatory and agencies

Kantar acquires Evidências, expands Brazilian presence

The company's acquisition signals the growing importance of understanding the Brazilian healthcare market and evidence-based healthcare management services.